Takeda invests €300M in plasma-derived therapies site in Lessines, Belgium

Takeda announced an investment of close to 300 million euros to expand its biotechnology manufacturing site in Lessines, Belgium, with a new production facility and a net-zero carbon emissions warehouse.

“The investment of close to 300 million euros encompasses a new production facility and a carbon net-zero emissions warehouse.”kickstartbiomanufacturing.be

• 1 source
• kickstartbiomanufacturing.beAwex/Essenscia - Takeda Invests Close to 300 Million Euros in its…Sep 13, 2022

Summarized from public sources; check the original articles before acting on it.